MIRANDA SUDDUTH: Open Payments
NPI 1962804211 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 96 payments from 14 companies in 2025. Trend: 2023 $1,372 · 2024 $1,456 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $594 |
| Novartis Pharmaceuticals Corporation | 28 | $225 |
| Amgen Inc. | 15 | $217 |
| Janssen Biotech, Inc. | 4 | $102 |
| UCB, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $60 |
| Mallinckrodt Hospital Products Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
Products named: RINVOQ, COSENTYX, SKYRIZI, OTEZLA, TREMFYA, Bimzelx, TALTZ, ACTHAR.
Industry payments across MS — which companies pay providers there.
